Entactogen and designer drugs (2)
Naito, H.
Chudoku Kenkyu Chudoku Kenkyukai Jun Kikanshi 23(2): 97-104
2010
ISSN/ISBN: 0914-3777 PMID: 20593645 Document Number: 638771
Document emailed within 1 workday
Related Documents
Henderson, F.; Kenny, G.N. 1999: Controversies in anaesthesia--designer drugs Annals of the Academy of Medicine Singapore 28(3): 434-439Mendive, J.M. 1998: The family physician and designer drugs Atencion Primaria 21(3): 180-181
Henderson, G.L. 1988: Designer drugs: past history and future prospects Journal of Forensic Sciences 33(2): 569-575
Misselbrook, G.P.; Hamilton, E.J. 2012: Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs Acute Medicine 11(3): 157-160
Wierzejska, R. 2014: Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism Developmental Period Medicine 18(3): 394-399
Farre Albaladejo, M. 1989: Neurologic complications of drug addiction. General aspects. Complications caused by cannabis, designer drugs and volatile substances Archivos de Neurobiologia 52(Suppl 1): 143-148
Rodríguez Arenas, M.A.; Barrio Anta, G.; de la Fuente de Hoz, L.; Royuela, L. 1997: Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants Revista Clinica Espanola 197(12): 804-809
Stoner Halpern, J. 2004: Designer disasters, a legacy to leave behind Disaster Management and Response: Dmr: An Official Publication of the Emergency Nurses Association 2(3): 65-66
Cohen, J. 2000: Designer labs: architecture discovers science Science 287(5451): 210-214
Wollrab, T.I. 1997: Designer "genes": the future of cattle cloning? Journal of the American Veterinary Medical Association 211(8): 960-962
McKibben, M.A. 1996: Designer drinks and drunkenness among schoolchildren. More "alcopops" have come on marker since study was done Bmj 313(7069): 1397; Author Reply 1397-8
Brüggemann, M.; Davies, N.P.; Rosewell, I.R. 1993: Designer mice: the production of human antibody repertoires in transgenic animals Year in Immunology 7: 33-40
Hajtó, J.; Marinescu, C.; Silva, N.R.F.A. 2014: Morphogenic designer--an efficient tool to digitally design tooth forms International Journal of Computerized Dentistry 17(3): 219-238
Järvinen, T.; Boyd, J. 2015: Designer-drug overdose patients treated by Helsinki Emergency Medical Services in 2009-2012 Duodecim; laaketieteellinen aikakauskirja 131(18): 1659-1666
Mayorov, O.Y. 2000: Virtual training simulator--designer of EEG signals for tutoring students and doctors to methods of quantitative EEG analysis (qEEG) Studies in Health Technology and Informatics 77: 573-577
O'Malley, P. 2011: The worldwide designer drug craze: bath salts behind the counter to get high: update for the clinical nurse specialist Clinical Nurse Specialist Cns 25(5): 224-225
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Askaa, B.; Horwitz, H.; Wøien, V.A.é; Høgberg, L.C.G.; Jürgens, G. 2014: The development from drug to designer drug Ugeskrift for Laeger 176(42)
Marek, J. 1985: On the non-specific antiinflammatory effects of other-than-antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs International Journal of Tissue Reactions 7(6): 475-504